Pregled bibliografske jedinice broj: 118481
Klinička primjena piperacilina/tazobaktama
Klinička primjena piperacilina/tazobaktama // Infektološki glasnik : znanstveno-stručni časopis za infektologiju, 22 (2002), 4; 159-161 (podatak o recenziji nije dostupan, članak, stručni)
CROSBI ID: 118481 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Klinička primjena piperacilina/tazobaktama
(Clinical use of piperacillin/tazobactam)
Autori
Škerk, Višnja ; Schonwald, Slavko ; Krhen, Ivan ; Čeljuska, Tošev ; Kopričanec , Maja ; Ledić Drvar, Danijela
Izvornik
Infektološki glasnik : znanstveno-stručni časopis za infektologiju (1331-2820) 22
(2002), 4;
159-161
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
piperacilin/tazobaktam; uroinfekcije
(piperacillin/tazobactam; uroinfections)
Sažetak
Piperacillin/tazobactam is the most effective combination of penicillin and beta-lactamase inhibitors in the treatment of infections caused by strains that excrete beta-lactamase of wider spectrum. In the hospital setting it is proved to reduce the risk from selecting strains that produce wide spectrum beta-lactamases, so that its administration contributes to decrease in the antimicrobial resistance rates. In the period from 2000 to 2002, 23 hospitalized patients with complicated urinary tract infections were treated with piperacillin/tazobactam at the University Hospital for Infectious Diseases "Dr. Fran Mihaljević", in Zagreb. A total of 20 patients were cured, and three experienced a relapse. Although piperacillin/tazobactam is one of the most expensive antimicrobial drugs, looking long-term, we believe that in certain patients it should be administered more often.
Izvorni jezik
Hrvatski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
Uključenost u ostale bibliografske baze podataka::
- Excerpta Medica